Synopsys 10-K 2020-10-31

Filed 2020-12-15. 2 sections, 407K characters. Original on sec.gov · Markdown · JSON

What changed since the 2019-10-31 10-KNew, removed and reworded risk factor headings, then every item sentence by sentence.

Cover and table of contents

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended October 31, 2020

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-19807

synopsyslogoa21.jpg

SYNOPSYS, INC.

(Exact name of registrant as specified in its charter)

Delaware56-1546236
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
690 East Middlefield Road,Mountain View,California94043
(Address of principal executive offices)(Zip Code)

(650) 584-5000

(Registrant’s telephone number, including area code)

Securities Registered Pursuant to Section 12(b) of the Act:

Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock, $0.01 par valueSNPSNasdaq Global Select Market

Securities Registered Pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Table of Contents

Large accelerated filerýAccelerated Filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its

internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting

firm that prepared or issued its audit report. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter was approximately $17.7 billion. Aggregate market value excludes an aggregate of approximately 38.9 million shares of common stock held by the registrant’s executive officers and directors and by each person known by the registrant to own 5% or more of the outstanding common stock on such date. Exclusion of shares held by any of these persons should not be construed to indicate that such person possesses the power, direct or indirect, to direct or cause the direction of the management or policies of the registrant, or that such person is controlled by or under common control with the registrant.

On December 10, 2020, 153,032,497 shares of the registrant’s Common Stock, $0.01 par value, were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s Proxy Statement relating to the registrant’s 2021 Annual Meeting of Stockholders, scheduled to be held on April 8, 2021, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Except as expressly incorporated by reference, the registrant’s Proxy Statement shall not be deemed to be part of this report.

Table of Contents

SYNOPSYS, INC.

ANNUAL REPORT ON FORM 10-K

Fiscal year ended October 31, 2020

TABLE OF CONTENTS

Page No.
PART I
Item 1.Business3
Item 1A.Risk Factors15
Item 1B.Unresolved Staff Comments27
Item 2.Properties28
Item 3.Legal Proceedings28
Item 4.Mine Safety Disclosures29
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities30
Item 6.Selected Financial Data32
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations32
Item 7A.Quantitative and Qualitative Disclosures About Market Risk47
Item 8.Financial Statements and Supplementary Data50
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure92
Item 9A.Controls and Procedures92
Item 9B.Other Information92
PART III
Item 10.Directors, Executive Officers and Corporate Governance

Showing the first 8K of 388K characters. Open the full section

Item 5. 03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On December 10, 2020, the Board of Directors amended and restated the bylaws of the Company (as so amended, the Amended and Restated Bylaws), effective immediately. The Amended and Restated Bylaws, among other things: (i) add the ability for stockholders holding not less than 20% of all outstanding shares of capital stock of the Company, which shares are held for not less than one (1) year prior to the date of the request, to request a

Table of Contents

special meeting of the stockholders; and (ii) provide that directors shall be elected by a majority of the votes cast by stockholders with respect to his or her election at a meeting for the election of directors, except that, if the number of nominees for election at any such meeting exceeds the number of directors to be elected at such meeting, each director to be so elected shall be elected by a plurality of votes cast by stockholders.

The foregoing summary of the Amended and Restated Bylaws does not purport to be complete and is qualified in its entirety by reference to the complete text of the Amended and Restated Bylaws, which are attached hereto as Exhibit 3.2 and are incorporated herein by reference.

Table of Contents

PART III

Item 10. Directors, Executive Officers and Corporate Governance

For information with respect to our executive officers, see Executive Officers of the Registrant in Part I, Item 1 of this Annual Report.

All other information required by this Item is incorporated herein by reference from our definitive Proxy Statement for the 2021 Annual Meeting (the Proxy Statement) scheduled to be held on April 8, 2021, as provided under the headings “Proposal 1: Election of Directors,” “Audit Committee Report,” and “Corporate Governance.”

Item 11. Executive Compensation

The information required by this Item is incorporated herein by reference from the Proxy Statement, as provided under the headings “Compensation Discussion and Analysis” (and all subheadings thereunder), "Executive Compensation Tables" (and all subheadings thereunder), "Director Compensation," “Compensation Committee Interlocks and Insider Participation,” and “Compensation Committee Report.”

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this Item is incorporated herein by reference from the Proxy Statement, as provided under the headings “Equity Compensation Plan Information” and “Security Ownership of Certain Beneficial Owners and Management.”

Item 13. Certain Relationships and Related Transactions and Director Independence

The information required by this Item is incorporated herein by reference from the Proxy Statement, as provided under the headings “Certain Relationships and Related Transactions” and “Corporate Governance” (under the subheading “Director Independence”).

Item 14. Principal Accountant Fees and Services

The information required by this Item is incorporated herein by reference from the Proxy Statement, as provided under the subheadings "Fees and Services of Independent Registered Public Accounting Firm" and "Audit Committee Pre-Approval Policies and Procedures" under the proposal titled “Ratification of Selection of Independent Registered Public Accounting Firm.”

Table of Contents

PART IV

Item 15. Exhibits and Financial Statement Schedules
(a)The following documents are filed as part of this Form 10-K:
(1)Financial Statements

The following documents are included as Part II, Item 8 of this Form 10-K:

Page
Report of Independent Registered Public Accounting Firm50
Consolidated Balance Sheets52
Consolidated Statements of Operations53
Consolidated Statements of Comprehensive Income54
Consolidated Statements of Stockholders’ Equity55
Consolidated Statements of Cash Flows56
Notes to Consolidated Financial Statements57
(2)Financial Statement Schedules

Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes herein.

(3)Exhibits

See Item 15(b) below.

(b)Exhibits

EXHIBIT INDEX

Exhibit NumberExhibit DescriptionIncorporated By ReferenceFiled or Furnished Herewith
FormFile No.ExhibitFiling Date
3.1Amended and Restated Certificate of Incorporation10-Q000-198073.19/15/2003
3.2Amended and Restated BylawsX
4.1Specimen Common Stock CertificateS-133-451384.32/24/1992 (effective date)
4.2Description of Synopsys' StockX

Table of Contents

Exhibit NumberExhibit DescriptionIncorporated By ReferenceFiled or Furnished Herewith
FormFile No.ExhibitFiling Date
10.1Amended and Restated Credit Agreement, dated November 28, 2016, among Synopsys as Borrower, the several Lenders from time to time parties thereto, Bank of America, N.A., the Bank of Tokyo-Mitsubishi UFJ, Ltd. and Wells Fargo Bank, N.A. as Co-Syndication Agents, HSBC Bank USA, N.A. and U.S. Bank N.A. as Co-Documentation Agents, JPMorgan Chase Bank, N.A., as Administrative Agent, and JPMorgan Chase Bank, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated, the Bank of Tokyo-Mitsubishi UFJ, Ltd. and Wells Fargo Securities, LLC, as Co-Lead Arrangers and Co-Bookrunners8-K000-1980710.111/30/2016
10.2Lease Agreement dated October 14, 2011 between Synopsys, Inc. and 690 E. Middlefield Road Fee, LLC, (“The October 14, 2011 Lease”)10-K000-1980710.1912/16/2011
10.2(i)†Notification of Change of Ownership of Leased Premises under The October 14, 2011 Lease—Effective May 9, 201210-K000-1980710.10(i)12/20/2012
10.2(ii)First Amendment to The October 14, 2011 Lease10-Q000-1980710.10(ii)3/4/2013
10.2(iii)Second Amendment to The October 14, 2011 Lease10-Q000-1980710.10(iii)5/22/2015
10.3*2006 Employee Equity Incentive Plan, as amended8-K000-1980710.44/15/2020
10.4*Form of Restricted Stock Unit Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan8-K000-1980710.54/6/2018
10.5*Form of Notice of Grant of Stock Options and Option Agreement under 2006 Employee Equity Incentive Plan8-K000-1980710.64/6/2018
10.6*Employee Stock Purchase Plan, as amended8-K000-1980710.74/15/2020
10.7*2017 Non-Employee Directors Equity Incentive Plan8-K000-1980710.84/10/2017
10.8*Form of Restricted Stock Grant Notice and Award Agreement under 2017 Non-Employee Directors Equity Incentive Plan10-K000-1980710.912/14/2017

Table of Contents

Exhibit NumberExhibit DescriptionIncorporated By ReferenceFiled or Furnished Herewith
FormFile No.ExhibitFiling Date
10.9*Form of Stock Options Grant Notice and Option Agreement under 2017 Non-Employee Directors Equity Incentive Plan10-K000-1980710.1012/14/2017
10.10*Deferred Compensation Plan as restated effective August 1, 200210-Q000-1980710.56/10/2004
10.11*Synopsys Amended and Restated Deferred Compensation Plan II10-Q000-1980710.233/9/2009
10.12Form of Indemnification Agreement for directors and executive officers8-K000-1980799.27/14/2011
10.13*Director’s and Officer’s Insurance and Company Reimbursement PolicyS-133-4513810.22/24/1992 (effective date)
10.14*Amended and Restated Employment Agreement, dated December 15, 2016 between Synopsys, Inc. and Dr. Aart de Geus8-K000-1980710.1612/21/2016
10.15*Amended and Restated Employment Agreement, dated December 15, 2016 between Synopsys, Inc. and Dr. Chi-Foon Chan8-K000-1980710.1712/21/2016
10.16*Executive Incentive Plan, as amended8-K000-1980710.1812/21/2016
10.17*Amended and Restated Executive Change of Control Severance Benefit Plan8-K000-1980710.1912/21/2016
10.18*Compensation Recovery Policy10-K000-1980710.4612/22/2008
21.1Subsidiaries of Synopsys, Inc.X
23.1Consent of KPMG LLP, Independent Registered Public Accounting FirmX
24.1Power of Attorney (see signature page to this Annual Report on Form 10-K)X
31.1Certification of Co-Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange ActX
31.2Certification of Co-Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange ActX
31.3Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange ActX

Table of Contents

Exhibit NumberExhibit DescriptionIncorporated By ReferenceFiled or Furnished Herewith
FormFile No.ExhibitFiling Date
32.1Certification of Co-Chief Executive Officers and Chief Financial Officer furnished pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States CodeX
101.INSInline XBRL Instance DocumentX
101.SCHInline XBRL Taxonomy Extension Schema DocumentX
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentX
101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentX
101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentX
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
  • Indicates a management contract, compensatory plan or arrangement.

† We have requested confidential treatment for certain portions of this document pursuant to an application for confidential treatment sent to the SEC. We omitted such portions from this filing and filed them separately with the SEC.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SYNOPSYS, INC.
Date: December 14, 2020By:/s/ Trac Pham
Trac Pham Chief Financial Officer (Principal Financial Officer)

Table of Contents

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Aart J. de Geus, Chi-Foon Chan and Trac Pham, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and reconstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

NameTitleDate
/S/ AART J. DE GEUSCo-Chief Executive Officer (Co-Principal Executive Officer) and Chairman of the Board of DirectorsDecember 14, 2020
Aart J. de Geus
/S/ CHI-FOON CHANCo-Chief Executive Officer (Co-Principal Executive Officer), President and DirectorDecember 14, 2020
Chi-Foon Chan
/S/ TRAC PHAMChief Financial Officer (Principal Financial Officer)December 14, 2020
Trac Pham
/S/ SUDHINDRA KANKANWADISVP, Chief Accounting Officer (Principal Accounting Officer)December 14, 2020
Sudhindra Kankanwadi
/S/ JANICE D. CHAFFINDirectorDecember 14, 2020
Janice D. Chaffin
/S/ BRUCE R. CHIZENDirectorDecember 14, 2020
Bruce R. Chizen
/S/ MERCEDES JOHNSONDirectorDecember 14, 2020
Mercedes Johnson
/S/ CHRYSOSTOMOS L. NIKIASDirectorDecember 14, 2020
Chrysostomos L. Nikias
/s/ JEANNINE SARGENTDirectorDecember 14, 2020
Jeannine Sargent
/S/ JOHN G. SCHWARZDirectorDecember 14, 2020
John G. Schwarz
/S/ ROY VALLEEDirectorDecember 14, 2020
Roy Vallee
/S/ STEVEN C. WALSKEDirectorDecember 14, 2020
Steven C. Walske